Related Experiment Video
Updated: Mar 18, 2026

14:58
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
10.4K
Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarct
Bulent Gulensoy1, Mete Karatay, Yavuz Erdem
1Ankara Training and Research Hospital, Neurosurgery Clinic, Ankara, Turkey.
Turkish Neurosurgery
|June 29, 2016
Summary
Decompressive hemicraniectomy is a life-saving treatment for malignant middle cerebral artery infarct. However, it is not effective for patients with a Glasgow Coma Scale score of 7 or below.
Area of Science:
- Neurosurgery
- Neurology
- Critical Care Medicine
Background:
- Malignant middle cerebral artery (MCA) infarcts often lead to severe brain swelling and neurological deficits.
- Decompressive hemicraniectomy (DHC) is a surgical intervention aimed at reducing intracranial pressure and improving outcomes in select patients.
Purpose of the Study:
- To evaluate the surgical treatment outcomes of decompressive hemicraniectomy in patients with malignant MCA infarct.
- To identify factors associated with favorable and unfavorable outcomes following DHC.
Main Methods:
- Retrospective analysis of 42 patients who underwent DHC for malignant MCA infarct.
- Evaluation of clinical condition, radiological findings, and Glasgow Outcome Scale (GOS) scores.
- Statistical analysis to determine associations between patient characteristics and surgical outcomes.
Main Results:
- A significant association was found between favorable outcomes and younger age, higher preoperative Glasgow Coma Scale (GCS) scores, shorter duration to surgery, and non-dominant hemisphere infarct.
- Patients with a GCS score of 7 or below preoperatively had universally poor outcomes.
- Out of 42 patients, 15 achieved a favorable outcome (GOS 4-5), while 27 had an unfavorable outcome (GOS 1-3).
Conclusions:
- Decompressive hemicraniectomy can be a life-saving procedure for malignant MCA infarct.
- DHC is not recommended for patients presenting with a GCS score of 7 or below due to poor prognosis.

